J&J is already a player in the market for drugs to treat resistant MDD with nasal spray antidepressant Spravato (esketamine ... cancer biotech IDRx and its KIT inhibitor for gastrointestinal ...

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

patients will still need to pay for the professional clinic visits required for supervised administration of the nasal spray. "While I think [listing Spravato on the PBS] is a useful step ...

A new nasal spray that uses a form of ketamine to treat difficult-to-treat depression will soon become more accessible to tens of thousands of Australians. Spravato, which contains esketamine ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

A controversial substance once tied to underground rave culture is now being hailed as a breakthrough for depression. The ...

In fact the damage was down to the repeated use of nasal decongestants, which Curtis had first used to overcome the bunged-up sensation brought on by a cold. Soon he was reaching for a spray ...

Dr. Purvi Parikh joins Saturday TODAY to break down why many may be experiencing worse symptoms this year, ways people can find relief and the correct way to use nasal spray.April 26, 2025 ...